Moderna, Inc. (BMV:MRNA)

Mexico flag Mexico · Delayed Price · Currency is MXN
583.94
-51.06 (-8.04%)
At close: Mar 31, 2025, 2:00 PM CST
-67.32%
Market Cap 219.13B
Revenue (ttm) 67.43B
Net Income (ttm) -74.20B
Shares Out n/a
EPS (ttm) -193.37
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 6,766
Average Volume 1,968
Open 566.00
Previous Close 635.00
Day's Range 550.00 - 591.60
52-Week Range 550.00 - 2,820.00
Beta n/a
RSI 33.60
Earnings Date May 1, 2025

About Moderna

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company’s respiratory vaccines include spikevax, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, su... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2010
Employees 5,800
Stock Exchange Mexican Stock Exchange
Ticker Symbol MRNA
Full Company Profile

Financial Performance

In 2024, Moderna's revenue was $3.24 billion, a decrease of -52.75% compared to the previous year's $6.85 billion. Losses were -$3.56 billion, -24.46% less than in 2023.

Financial numbers in USD Financial Statements

News

There is no news available yet.